Corrigendum to "The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target" [Drug Resistance Updates 29 (2016) 47-53]
Drug Resist Updat. 2017 Jan:30:63.
doi: 10.1016/j.drup.2017.01.003.
Epub 2017 Feb 8.
1 Inserm UMR 1199, Biology and Innovative Therapeutics for Locally Aggressive Cancers (BioTICLA), Caen, France; Normandie University of Caen, France; Service de Chirurgie Thoracique, Hôpital Pasteur, Nice, France.
2 ISPB, Faculté de Pharmacie, Lyon, France; Université Lyon 1, Lyon, France; INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, France. Electronic address: hubert.lincet@univ-lyon1.fr.